Search research articles
Contact Us
Filters
Showing results (11-20 of 34) with videos related to
Page
of 4
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 7, 2012
Persistence, adherence, and toxicity with oral CMF in older women with early-stage breast cancer (Adherence Companion Study 60104 for CALGB 49907)
K J Ruddy, B N Pitcher, L E Archer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 25, 2013
Predictors of recovery of ovarian function during aromatase inhibitor therapy
N L Henry, R Xia, M Banerjee, et al.
Breast (Edinburgh, Scotland)
|
June 30, 2022
Moderate penetrance genes complicate genetic testing for breast cancer diagnosis: ATM, CHEK2, BARD1 and RAD51D
R Graffeo, H Q Rana, F Conforti, et al.
Breast Cancer Research and Treatment
|
November 15, 2011
Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer
L C Collins, J D Marotti, S Gelber, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 9, 2015
Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies
M Lambertini, M Ceppi, F Poggio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 5, 2025
Circulating tumor DNA clearance as a predictive biomarker of pathologic complete response in patients with solid tumors treated with neoadjuvant immune checkpoint inhibitors: a systematic review and meta-analysis
C Valenza, E F Saldanha, Y Gong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 11, 2016
Research needs in breast cancer
F Cardoso, N Harbeck, C H Barrios, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 16, 2001
Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer
H J Burstein, I Kuter, S M Campos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2020
ESO-ESMO 4th International Consensus Guidelines for Breast Cancer in Young Women (BCY4)
S Paluch-Shimon, F Cardoso, A H Partridge, et al.
ESMO Open
|
October 25, 2023
Safety of pregnancy after breast cancer in young women with hormone receptor-positive disease: a systematic review and meta-analysis
L Arecco, E Blondeaux, M Bruzzone, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 34) with videos related to
Sort By:
Page
of 4
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 7, 2012
Persistence, adherence, and toxicity with oral CMF in older women with early-stage breast cancer (Adherence Companion Study 60104 for CALGB 49907)
K J Ruddy, B N Pitcher, L E Archer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 25, 2013
Predictors of recovery of ovarian function during aromatase inhibitor therapy
N L Henry, R Xia, M Banerjee, et al.
Breast (Edinburgh, Scotland)
|
June 30, 2022
Moderate penetrance genes complicate genetic testing for breast cancer diagnosis: ATM, CHEK2, BARD1 and RAD51D
R Graffeo, H Q Rana, F Conforti, et al.
Breast Cancer Research and Treatment
|
November 15, 2011
Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer
L C Collins, J D Marotti, S Gelber, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 9, 2015
Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies
M Lambertini, M Ceppi, F Poggio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 5, 2025
Circulating tumor DNA clearance as a predictive biomarker of pathologic complete response in patients with solid tumors treated with neoadjuvant immune checkpoint inhibitors: a systematic review and meta-analysis
C Valenza, E F Saldanha, Y Gong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 11, 2016
Research needs in breast cancer
F Cardoso, N Harbeck, C H Barrios, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 16, 2001
Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer
H J Burstein, I Kuter, S M Campos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2020
ESO-ESMO 4th International Consensus Guidelines for Breast Cancer in Young Women (BCY4)
S Paluch-Shimon, F Cardoso, A H Partridge, et al.
ESMO Open
|
October 25, 2023
Safety of pregnancy after breast cancer in young women with hormone receptor-positive disease: a systematic review and meta-analysis
L Arecco, E Blondeaux, M Bruzzone, et al.
Page
of 4